no statement of use filed
on 25 Apr 2022
Last Applicant/ Owned by
170 Park Avenue
lorham Park
NJ
07932
Serial Number
87863040 filed on 04th Apr 2018
Registration Number
N/A
Correspondent Address
Camille M. Miller
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chor Read More
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's isease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen
No 87863040
No Service/Collective Mark
No CLTY0513US/
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
25th Apr 2022 | ABANONMENT - NO USE STATEMENT ILE |
25th Apr 2022 | ABANONMENT NOTICE E-MAILE - NO USE STATEMENT ILE |
08th Dec 2021 | APPLICANT/CORRESPONENCE CHANGES (NON-RESPONSIVE) ENTERE |
16th Nov 2021 | TEAS POST PUBLICATION AMENMENT RECEIVE |
24th Aug 2021 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
23rd Aug 2021 | CASE ASSIGNE TO INTENT TO USE PARALEGAL |
23rd Aug 2021 | SOU EXTENSION 5 GRANTE |
19th Aug 2021 | SOU TEAS EXTENSION RECEIVE |
19th Aug 2021 | SOU EXTENSION 5 ILE |
20th Feb 2021 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |